Report

Our reports provide latest industry trends, forecasts, company profiles, competitive landscape, and strategic insights.

Asset 41 2
160 1608792 circle document icon png transparent png

Europe Embolotherapy Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Embolic Agent and Support Device), Disease Indication (Cancer, Peripheral Vascular Disease, Neurological Disease, Urological and Nephrological Disorder, Gastrointestinal Disorder, and Other), Procedure [Transcatheter Arterial Embolization (TAE), Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT), and Transarterial Chemoembolization (TACE)], and End User (Hospital & Clinic, Ambulatory Surgery Center, and Other End User)

The embolotherapy market in Europe is expected to grow from US$ 1,050.81 million in 2022 to US$ 1,638.92 million by 2028. It is estimated to grow at a CAGR of 7.7% from 2022 to 2028.

Rising Prevalence of Cancer Drives Growth of Embolotherapy Market in Europe

The five most common types of cancer are breast cancer, prostate cancer, cervical cancer, lung cancer, and colorectal cancer. Among these five cancer types, the leading cause of cancer-related death is lung cancer. Even though breast cancer has at least a 25% higher incidence among women, cervical carcinoma was the leading cause of death in 2020. In Denmark, the highest cancer rate for men and women combined was 334.9 people per 100,000. The age-standardized rate was at least 300 per 100,000 for ten countries—Denmark, Hungary, Ireland, Belgium, France, Australia, the Netherlands, Norway, France (New Caledonia), and Slovenia. In 2018, an estimated 233,000 women and 265,000 men in Germany were newly diagnosed with cancer. The total number of new cases per year has stagnated at around 500,000 for about ten years. Embolization is used to stop bleeding or block blood flow to a tumor or abnormal tissue area. It is also used to treat liver and kidney cancer and neuroendocrine tumors. Embolizing agents, including embolic microspheres (beads), are used to restrict the vascular supply of tumors and can be loaded with chemotherapeutic medicines, which elute and diffuse into the tissue. The vascular embolization device (previously the arterial embolization device) is intended to control hemorrhaging due to aneurysms, certain tumor types, and arteriovenous malformations. The pipeline embolization device is used for the treatment of large and giant wide-neck intracranial aneurysms in the internal carotid artery. It helps prevent aneurysms and tumors from growing and causing harm to essential organs. Thus, the rising prevalence of cancer cases is creating a high demand for embolotherapy products.

Market Overview

The embolotherapy market in Europe is segmented into Germany, France, the UK, Italy, Spain, and the rest of Europe. The market growth in the region is attributed to the increasing prevalence of cancers and brain aneurysms; rising preference for minimally invasive procedures; and surging investments, funds, and grants by public–private organizations for research. However, a dearth of skilled surgeons restrains the market growth. Germany is one of the significantly developed economies in Europe. Healthcare expenditure is increasing in Germany. Germany’s spending on healthcare is higher (11% of its wealth) than the other countries spend (9.8% in the UK). The country has more doctors and hospital beds per patient than the UK. As per the data published in “The Burden of Stroke in Europe” report conducted by King’s College London for the Stroke Alliance for Europe, the number of stroke cases is around 88,922, which is 51.7 strokes per 100,000 inhabitants annually in Germany. The prevalence of stroke in Germany was around 526,774, accounting for 338.5 strokes per 100,000 inhabitants. The country also has a significant mortality rate of stroke, i.e., 75,861 deaths due to stroke per year. The incidence of strokes in Germany is estimated to increase by 30% by 2035. Also, the prevalence and mortality rates are expected to rise to 19% and 40%, respectively, by 2035.

Europe Embolotherapy Market Revenue and Forecast to 2028 (US$ Million)

Europe Embolotherapy Market Segmentation

The Europe embolotherapy market is segmented into product, disease indication, procedure, end user, and country.
Based on product, the market is segmented into embolic agents and support devices. The embolic agents segment registered the largest market share in 2022. Based on disease indication, the market is categorized into cancer, neurological diseases, urological and nephrological disorders, peripheral vascular diseases, gastrointestinal disorders, and others. The cancer segment held the largest market share in 2022. Based on procedure, the Europe embolotherapy market is segmented into transcatheter arterial embolization (TAE), transcatheter arterial radioembolization/selective internal radiation therapy, and transarterial chemoembolization (TACE). The transcatheter arterial embolization (TAE) segment held the largest market share in 2022. Based on end user, the Europe embolotherapy market is segmented into hospitals and clinics, ambulatory surgical centers, and other end users. The hospitals and clinics segment held the largest market share in 2022. Based on country, the market is segmented into Germany, France, the UK, Italy, Spain, and Rest of Europe. Germany dominated the market share in 2022. Abbott Laboratories; Boston Scientific Corporation; Cook Medical LLC; Johnson & Johnson; Medtronic; Acandis GmbH; Balt USA LLC; Stryker Corporation; Guerbet LLC; and Terumo Corporation are the leading companies operating in the embolotherapy market in the region.

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Embolotherapy Market – by Product
1.3.2 Europe Embolotherapy Market – by Disease Indication
1.3.3 Europe Embolotherapy Market – by Procedure
1.3.4 Europe Embolotherapy Market – by End User
1.3.5 Europe Embolotherapy Market– By Country
2. Europe Embolotherapy Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Embolotherapy Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Expert Opinion
5. Europe Embolotherapy Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Boosting Incidence of Cancer Cases
5.1.2 Widening Patient Preference for Minimally Invasive Procedures
5.2 Market Restraints
5.2.1 Availability of Other Alternative Therapies
5.3 Market Opportunity
5.3.1 Burgeoning Applications of Embolotherapy
5.4 Market Trend
5.4.1 Widening Use of Liquid Embolic Agents
5.5 Impact analysis
6. Europe Embolotherapy Market Analysis
6.1 Europe Embolotherapy Market Revenue Forecast and Analysis
7. Europe Embolotherapy Market – by Product
7.1 Overview
7.2 Europe Embolotherapy Market Revenue Share, by Products 2022 & 2028 (%)
7.3 Embolic Agents
7.3.1 Overview
7.3.2 Embolic Agents: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
7.3.3 Microspheres
7.3.3.1 Overview
7.3.3.2 Microspheres: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
7.3.4 Embolic Coils
7.3.4.1 Overview
7.3.4.2 Embolic Coils: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
7.3.5 Embolic Plug Systems
7.3.5.1 Overview
7.3.5.2 Embolic Plug Systems: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
7.3.6 Detachable Balloons
7.3.6.1 Overview
7.3.6.2 Detachable Balloons: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
7.3.7 Liquid Embolic Agents
7.3.7.1 Overview
7.3.7.2 Liquid Embolic: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
7.3.8 Others
7.3.8.1 Overview
7.3.8.2 Others: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
7.4 Support Devices
7.4.1 Overview
7.4.2 Support Devices: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
7.4.3 Microcatheters
7.4.3.1 Overview
7.4.3.2 Microcatheters: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
7.4.4 Guidewires
7.4.4.1 Overview
7.4.4.2 Guidewires: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
8. Europe Embolotherapy Market Analysis – by Disease Indication
8.1 Overview
8.2 Europe Embolotherapy Market Revenue Share, by Disease Indication 2022 & 2028 (%)
8.3 Cancer
8.3.1 Overview
8.3.2 Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.3.2.1 Liver Cancer
8.3.2.1.1 Overview
8.3.2.1.2 Liver Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.3.2.2 Kidney Cancer
8.3.2.2.1 Overview
8.3.2.2.2 Kidney Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.3.2.3 Other Cancers
8.3.2.3.1 Overview
8.3.2.3.2 Other Cancers: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Peripheral Vascular Diseases
8.4.1 Overview
8.4.2 Peripheral Vascular Diseases: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Neurological Diseases
8.5.1 Overview
8.5.2 Neurological Diseases: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Urological and Nephrological Disorders
8.6.1 Overview
8.6.2 Urological and Nephrological Disorders: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Gastrointestinal Disorders
8.7.1 Overview
8.7.2 Gastrointestinal Disorders: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
9. Europe Embolotherapy Market Analysis – by Procedure
9.1 Overview
9.2 Europe Embolotherapy Market Revenue Share, by Procedure 2022 & 2028 (%)
9.3 Transcatheter Arterial Embolization (TAE)
9.3.1 Overview
9.3.2 Transcatheter Arterial Embolization (TAE): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT)
9.4.1 Overview
9.4.2 Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Transarterial Chemoembolization (TACE)
9.5.1 Overview
9.5.2 Transarterial Chemoembolization (TACE): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
10. Europe Embolotherapy Market Analysis – By End User
10.1 Overview
10.2 Europe Embolotherapy Market Revenue Share, By End User 2022 & 2028 (%)
10.3 Hospitals and Clinics
10.3.1 Overview
10.3.2 Hospitals: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Ambulatory Surgical Centers
10.4.1 Overview
10.4.2 Ambulatory Surgical Centers: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
10.5 Other End Users
10.5.1 Overview
10.5.2 Other End Users: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11. Europe Embolotherapy Market – Country Analysis
11.1 Europe Embolotherapy Market
11.1.1 Europe: Embolotherapy Market, by Country, 2022 & 2028 (%)
11.1.1.1 Germany: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.1 Germany: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.2 Germany Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.2.1 Germany Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.2.2 Germany Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.3 Germany Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.3.1 Germany Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.4 Germany Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
11.1.1.1.5 Germany Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)
11.1.1.2 France: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.1 France: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.2 France Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.2.1 France Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.2.2 France Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.3 France Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.3.1 France Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.4 France Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
11.1.1.2.5 France Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)
11.1.1.3 UK: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.1 UK: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.2 UK, Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.2.1 UK, Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.2.2 UK, Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.3 UK, Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.3.1 UK, Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.4 UK, Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
11.1.1.3.5 UK, Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)
11.1.1.4 Italy: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.4.1 Italy: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.4.2 Italy Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
11.1.1.4.2.1 Italy Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
11.1.1.4.2.2 Italy Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
11.1.1.4.3 Italy Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
11.1.1.4.3.1 Italy Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)
11.1.1.4.4 Italy Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
11.1.1.4.5 Italy Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)
11.1.1.5 Spain: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.5.1 Spain: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.5.2 Spain Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
11.1.1.5.2.1 Spain Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
11.1.1.5.2.2 Spain Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
11.1.1.5.3 Spain Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
11.1.1.5.3.1 Spain Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)
11.1.1.5.4 Spain Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
11.1.1.5.5 Spain Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)
11.1.1.6 Rest of Europe: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.6.1 Rest of Europe: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
11.1.1.6.2 Rest of Europe Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
11.1.1.6.2.1 Rest of Europe Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
11.1.1.6.2.2 Rest of Europe Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
11.1.1.6.3 Rest of Europe Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
11.1.1.6.3.1 Rest of Europe Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)
11.1.1.6.4 Rest of Europe Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
11.1.1.6.5 Rest of Europe Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)
12. Europe Embolotherapy Market –Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 Abbott Laboratories
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Boston Scientific Corporation
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Cook Medical LLC
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Johnson & Johnson
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Medtronic
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Acandis GmbH
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Balt USA LLC
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Stryker Corporation
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Guerbet LLC
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Terumo Corporation
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms

LIST OF TABLES

Table 1. Germany Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 2. Germany Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
Table 3. Germany Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
Table 4. Germany Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 5. Germany Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)
Table 6. Germany Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
Table 7. Germany Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)
Table 8. France Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 9. France Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
Table 10. France Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
Table 11. France Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 12. France Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)
Table 13. France Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
Table 14. France Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)
Table 15. UK, Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 16. UK, Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
Table 17. UK, Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
Table 18. UK, Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 19. UK, Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)
Table 20. UK, Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
Table 21. UK, Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)
Table 22. Italy Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 23. Italy Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
Table 24. Italy Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
Table 25. Italy Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 26. Italy Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)
Table 27. Italy Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
Table 28. Italy Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)
Table 29. Spain Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 30. Spain Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
Table 31. Spain Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
Table 32. Spain Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 33. Spain Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)
Table 34. Spain Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
Table 35. Spain Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)
Table 36. Rest of Europe Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 37. Rest of Europe Embolotherapy Market, by Embolic Agents – Revenue and Forecast to 2028 (US$ Million)
Table 38. Rest of Europe Embolotherapy Market, by Support Devices – Revenue and Forecast to 2028 (US$ Million)
Table 39. Rest of Europe Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 40. Rest of Europe Embolotherapy Market, by Cancer – Revenue and Forecast to 2028 (US$ Million)
Table 41. Rest of Europe Embolotherapy Market, by Procedure– Revenue and Forecast to 2028 (US$ Million)
Table 42. Rest of Europe Embolotherapy Market, By End User– Revenue and Forecast to 2028 (US$ Million)
Table 43. Organic Developments Done by Companies
Table 44. Inorganic Developments Done by Companies
Table 45. Glossary of Terms, Europe Embolotherapy Market

LIST OF FIGURES

Figure 1. Europe Embolotherapy Market Segmentation
Figure 2. Europe Embolotherapy Market, By Country
Figure 3. Europe Embolotherapy Market Overview
Figure 4. Embolic Agents Held Largest Share of Product Segment in Embolotherapy Market
Figure 5. Embolotherapy Market in the Europe Region to Show Remarkable Growth During Forecast Period
Figure 6. Europe Embolotherapy Market, Industry Landscape
Figure 7. Europe PEST Analysis
Figure 8. Europe Embolotherapy Market Impact Analysis of Drivers and Restraints
Figure 9. Europe Embolotherapy Market– Revenue Forecast and Analysis – 2020- 2028
Figure 10. Europe Embolotherapy Market Revenue Share, by Products 2022 & 2028 (%)
Figure 11. Embolic Agents: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
Figure 12. Microspheres: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
Figure 13. Embolic Coils: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
Figure 14. Embolic Plug Systems: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
Figure 15. Detachable Balloons: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
Figure 16. Liquid Embolic: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
Figure 17. Others: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
Figure 18. Support Devices: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
Figure 19. Microcatheters: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
Figure 20. Guidewires: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)
Figure 21. Europe Embolotherapy Market Revenue Share, by Disease Indication 2022 & 2028 (%)
Figure 22. Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Liver Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Kidney Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Other Cancers: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Peripheral Vascular Diseases: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Neurological Diseases: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Urological and Nephrological Disorders: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Gastrointestinal Disorders: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Others: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Europe Embolotherapy Market Revenue Share, by Procedure 2022 & 2028 (%)
Figure 32. Transcatheter Arterial Embolization (TAE): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Transarterial Chemoembolization (TACE): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Europe Embolotherapy Market Revenue Share, By End User 2022 & 2028 (%)
Figure 36. Hospitals: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Ambulatory Surgical Centers: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. Other End Users: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 39. Europe: Embolotherapy Market, by Key Country – Revenue (2022) (US$ Million)
Figure 40. Europe: Embolotherapy Market, by Country, 2022 & 2028 (%)
Figure 41. Germany: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42. France: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 43. UK: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 44. Italy: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45. Spain: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)
Figure 46. Rest of Europe: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe embolotherapy market.
● Highlights key business priorities in order to assist companies to realign their business strategies
● The key findings and recommendations highlight crucial progressive industry trends in the Europe embolotherapy market, thereby allowing players across the value chain to develop effective long-term strategies
● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
● Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the embolotherapy market, as well as those hindering it
● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

The List of Companies – Europe Embolotherapy Market

● Abbott Laboratories
● Boston Scientific Corporation
● Cook Medical LLC        
● Johnson & Johnson
● Medtronic
● Acandis GmbH  
● Balt USA LLC
● Stryker Corporation
● Guerbet LLC
● Terumo Corporation

Pricing

$3,000.00$5,000.00

Have a Query?

Have a Question?

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

GET FREE SAMPLE PDF

× Enquire Now